GC-MS Compound Identification in Phaseolus vulgaris - A Low-Cost Cataract Prevention Food

Phaseolus vulgaris is one of the most widely used traditional remedies for diabetes mellitus. Over a thousand medicinal plants have been found to contain anti-diabetic chemicals, the bulk of which have long been used in traditional medicine. The pharmacological significance of eating Phaseolus vulgaris in diabetics has been intensively explored in order to identify the several bioactive components responsible for their diabetes-controlling benefits. Researchers have previously linked the eating of P. vulgaris as a possible protective factor against cataract surgery based on their findings on the evaluation of beans and other vegetables. This study was driven by the need to find more bioactive chemicals that are active in the management of diabetes and the prevention of cataract, which is one of the disease's consequences. In Ado-Ekiti, Nigeria, Phaseolus vulgaris is a leguminous crop that is widely consumed. Phaseolus vulgaris was purchased from two different sources, pulverized with a Sumeet CM/L 2128945 grinder, and extracted with methanol and ethanol. The extracts were concentrated. The bioactive components in the extracts were identified using GC-MS. The ethanolic extract includes twelve bioactive compounds, while the methanolic extract contains ten. The ethanol extract contains neophytadiene, β-amyrin, and squalene, among other chemicals. Neophytadiene, 1,2-benzisothiazol-3-amine, TBDMS derivative, and 1-Methyl-3-phenylindole were found in methanol extract. Both extracts contain bioactive chemicals that have been shown to have anti-diabetic and cataract-prevention properties in humans. Finally, the discovery of these various beneficial components lends credence to scientific proof that Phaseolus vulgaris can be consumed by diabetics.